Non-Bacterial Urinary Tract Infections: Unveiling a Hidden Challenge in Urology and Infectious Disease Research

• Authors: Falah Hasan Obayes AL-Khikani , Aalae Salman Ayit
• Languages of publication: EN

Abstracts

EN

Non-bacterial urinary tract infections (UTIs) remain a critically understudied domain within urology and infectious disease, overshadowed by the well-characterized bacterial paradigm despite their significant clinical impact. This review provides an exhaustive analysis of non-bacterial UTIs, encompassing viral (e.g., adenovirus, BK virus), fungal (e.g., Candida spp.), parasitic (e.g., Schistosoma haematobium), and non-infectious etiologies (e.g., interstitial cystitis, chemical irritants, autoimmune conditions). These conditions often evade conventional diagnostics, leading to misdiagnosis, inappropriate antibiotic use, and chronic patient suffering. We explore the pivotal roles of the urinary microbiome and immune dysregulation, integrating cutting-edge research on dysbiosis, neuroimmune interactions, and environmental triggers. Diagnostic challenges are dissected alongside innovative solutions, including metagenomics, AI-driven tools, and novel biomarkers. Therapeutically, we propose a multifaceted approach – pathogen-specific treatments, immunomodulation, microbiome restoration, and patient-centered strategies supported by emerging modalities like nanoparticle drug delivery and dietary interventions. Enhanced clinician awareness and standardized protocols are advocated to combat antimicrobial resistance and improve outcomes. This expansive review, enriched with multidisciplinary insights and forward-thinking proposals, seeks to galvanize global research efforts to address the complexities of non-bacterial UTIs comprehensively.

Keywords

EN

Non-bacterial UTI; antimicrobial resistance; diagnostic challenges; dysbiosis; fungal UTI; immune dysregulation; infectious disease; interstitial cystitis; urinary microbiome; urology; viral UTI

Discipline

• MEDICAL_BIOLOGY: MEDICAL BIOLOGY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2025
• Volume: 60
• Pages: 181-194

Contributors

author

Falah Hasan Obayes AL-Khikani

• Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf, Iraq

author

Aalae Salman Ayit

• Department of Microbiology, Al-Shomali General Hospital, Babylon Health Directorate, Babylon, Iraq

References

• [1] Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5): 269-84
• [2] AL-Khikani FH, Alhusayni AA, Jasim SH. Nitrofurantoin and Fosfomycin Activity for Uropathogenic Escherichia Coli with Extended-Spectrum Beta-Lactamase. Medical Journal of Dr. DY Patil University. 2024 Nov 1; 17(Suppl 2): S417-8
• [3] De Nisco NJ, Neugent M, Mayer J, et al. Direct detection of tissue-resident bacteria and chronic inflammation in the bladder wall of postmenopausal women with recurrent urinary tract infection. J Mol Biol. 2019; 431(22): 4368-79
• [4] Hamid BH, Saadoun SA, Al-Khikani FH. The Effect of Povidone Iodine Combined with Sodium Bicarbonate against Staphylococcus aureus and Escherichia coli, the Antagonism and Synergism. Assam Journal of Internal Medicine. 2024 Jul 1; 14(2): 119-23
• [5] AL-Khikani FH, Abdullah HY, Karkaz HM. Evaluation the combination of amoxyclav with amikacin and ceftriaxone against Escherichia coli sepsis. Microbes and Infectious Diseases. 2024 Nov 1; 5(4): 1425-30
• [6] Siddiqui ZA, Abuhamda FK, Memon NH, Mohsin S, Mohsin SA. Urinary tract infection: a case from Puerto Rico. Infect Dis Clin Pract. 2005; 13(3): 152-4
• [7] Ciani O, Grassi D, Tarricone R. An economic perspective on urinary tract infection: the costs of resignation. Clin Drug Investig. 2013; 33(4): 255-61
• [8] Alhusayni AA, AL-Khikani FH. Is There an Apparent Difference in the Activity of Amikacin, Levofloxacin, and other Antibiotics Against Staphylococcus Species? Assam Journal of Internal Medicine. 2024 Jul 1; 14(2): 132-3
• [9] Clemens JQ, Mullins C, Kusek JW, et al. The MAPP research network: Design, patient characterization and operations. BMC Urol. 2015; 14(1): 1-10
• [10] Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008; 41(1): 11-8
• [11] Hirsch HH, Randhawa P, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013; 13(s4): 179-88
• [12] Silva CR, Martins VC, Oliveira JR, Valêsio ML, Tanuri A. BK virus and human immunodeficiency virus coinfection in brazilian renal transplant recipients. Int J Infect Dis. 2010; 14: e55
• [13] Ito M, Hirabayashi N, Uno Y, Nakayama A, Asai Y. Necrotizing adenovirus cystitis associated with bone marrow transplantation. Bone Marrow Transplant. 2015; 50(8): 1151-2
• [14] Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015; 30(2): 209-17
• [15] Raman V, Agarwal A, Thakral D, Yadav SP. Epstein-Barr virus-associated hemorrhagic cystitis in a pediatric allogenic bone marrow transplant recipient. Pediatr Transplant. 2013; 17(7): E125-E129
• [16] Paduch DA. Viral lower urinary tract infections. Curr Urol Rep. 2007; 8(4): 324-35
• [17] Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections—epidemiology. Clin Infect Dis. 2011; 52(suppl_6): S433-S436
• [18] Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011; 52(suppl_6): S437-S451
• [19] Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun. 2009; 71(8): 4333-40
• [20] Rodrigues CF, Silva S, Henriques M. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis. 2016; 35(1): 1-18
• [21] Siddiqui AA, Berk SL, Siddiqui A, Berk S. Diagnosis of cryptococcus neoformans infections. In StatPearls. StatPearls Publishing; 2021
• [22] Botelho MC, Machado JC, da Costa JMC. Schistosoma haematobium and bladder cancer: what lies beneath? Virulence. 2015; 6(1): 6-9
• [23] Mielczarek E, Blaszkowska J. Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection. 2016; 44(4): 447-58
• [24] Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014; 383(9936): 2253-64
• [25] Lingscheid T, Kurth F, Clerinx J, et al. Schistosomiasis in European travelers and migrants: analysis of 14 years TropNet surveillance data. Am J Trop Med Hyg. 2017; 97(2): 567-74
• [26] Hussen BM, Qader AM, Ahmed HM. Enterobius vermicularis causing acute urinary retention in an adult female. Int J Surg Case Rep. 2016; 20: 33-5.
• [27] Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015; 193(5): 1545-53
• [28] Kouzoukas DE, Meyer-Siegler KL, Ma F, Westlund KN, Hunt DE, Vera PL. Macrophage migration inhibitory factor mediates PAR-induced bladder pain. PLoS One. 2016; 11(2): e0127628
• [29] Jiang J, Li M, Wei T, Yan Z, Wang J. Fatal acute pancreatitis associated with renal and pulmonary involvement in a patient with systemic lupus erythematosus: a case report. Medicine. 2016; 95(16)
• [30] Howell AB, Botto H, Combescure C, et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010; 10(1): 1-11
• [31] AL-Khikani FH, Nima AR, Salah AM, Hadi BI, Badran BH, Ghazi BK, Darwes TF, Abd Alabaas HM, Tourki TA, Noor TH. Activity of sodium bicarbonate against Escherichia Coli. Medical Science Journal for Advance Research. 2023 Aug 29; 4(3): 183-8
• [32] Wolfe AJ, Toh E, Shibata N, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012; 50(4): 1376-83
• [33] Thomas-White KJ, Hilt EE, Fok C, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016; 27(5): 723-33
• [34] Brubaker L, Nager CW, Richter HE, et al. Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J. 2014; 25(9): 1179-84
• [35] Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus. 2018; 4(1): 128-38
• [36] Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract—a role beyond infection. Nat Rev Urol. 2015; 12(2) :81-90
• [37] AL-Khikani FH, Hamdan Jasim S, AbedulameerAlhusayni A. Evaluation Sensitivity of Uropathogenic E. coli and Gram Positive Cocci to Fosfomycin and Amoxyclav. Journal of Pharmaceutical and Applied Chemistry. 2024 Jan 1; 10(1): 1-1
• [38] AL-Khikani FH. Trends in antibiotic resistance of major uropathogens. Matrix Science Medica. 2020 Oct 1; 4(4): 108-11
• [39] Hussein HM, Al-Khikani FH, Mohammed JB, Hassan BH, Hamza TM, Ali BH, Shaalan BA, Mohammed HJ, Ali HJ, Mohammed HF. Vinegar Activity against Clinically Isolated Escherichia Coli. Assam Journal of Internal Medicine. 2024 Jan 1; 14(1): 8-12
• [40] Amabebe E, Anumba DOC. The vaginal microenvironment: the physiologic role of lactobacilli. Front Med. 2018; 5: 181
• [41] Fouts DE, Pieper R, Szpakowski S, et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012; 10(1): 1-17
• [42] Abdullah HY, Al-Khikani FH, Karkaz HM, Abdulhussein HA. The Possible Synergism Effect of Amoxyclav Combined with Gentamicin and Paracetamol against Blood Stream Escherichia coli. Assam Journal of Internal Medicine. 2024 Jan 1; 14(1): 19-22
• [43] Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017; 15(1): 1-17
• [44] Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, et al. Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages. Curr Microbiol. 2018; 75(7): 939-47
• [45] Gamper M, Viereck V, Geissbühler V, et al. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C. Int Urogynecol J. 2013; 24(12): 2049-57
• [46] Alhusayni AA, AL-Khikani FH, AL-Kharawy BA. Relationships between some antibiotics resistance of human intestinal E. coli and antibiotic consumption. Microbes and Infectious Diseases. 2024 Mar 5. 10.21608/mid.2024.261531.1751
• [47] Grundy L, Caldwell A, Brierley SM. Mechanisms underlying overactive bladder and interstitial cystitis/painful bladder syndrome. Front Neurosci. 2018; 12: 931
• [48] Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013; 93(2): 653-680
• [49] Jhang JF, Kuo HC. Pathomechanism of interstitial cystitis/bladder pain syndrome and mapping the heterogeneity of disease. Int Neurourol J. 2016; 20(Suppl 2): S95
• [50] Ochs RL, Stein TW, Peebles CL, Gittes RF, Tan EM. Autoantibodies in interstitial cystitis. J Urol. 2011; 143(3):5 07-10
• [51] Marshall JL, Hurst JH, Cricco-Schmidt LM. Juvenile sjogren's syndrome and recurrent parotitis. Curr Allergy Asthma Rep. 2014; 14(2): 422
• [52] Yoshikawa T, Watanabe T, Minagawa S, et al. IgG4-related disease presenting as bladder wall thickening: a case report. BMC Urol. 2012; 12: 1-5
• [53] Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012; 42(1): 102-11
• [54] Gupta S, Gill D, Poole K, Agarwal A. Systemic immunosuppressants in the treatment of interstitial cystitis: a systematic review. Curr Urol Rep. 2015; 16(5): 1-10
• [55] Crescenze IM, Tucky B, Li J, Moore C, Shoskes DA. Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis/bladder pain syndrome. Urology. 2019; 124: 43-47
• [56] Parsons CL, Stein P, Zupkas P, et al. Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol. 2015; 178(6): 2665-70
• [57] Fry CH, Daneshgari F, Thor K, et al. Animal models and their use in understanding lower urinary tract dysfunction. Neurourol Urodyn. 2014; 33(3): 272-9
• [58] Price TK, Dune T, Hilt EE, et al. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol. 2016; 54(5): 1216-22
• [59] Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52(5): e103-e120
• [60] AL-Khikani FH, Ahmeed HW, Khudair KK. Gentamicin And Ciprofloxacin Sensitivity Against E. Coli Clinically Isolated From Urinary Tract Infection. Medical Science Journal for Advance Research. 2023 Aug 29; 4(3): 178-82
• [61] Pinto AM, Costa JS, Viana-Niero C, et al. Polyomavirus JC and BK in the urine of HIV-infected subjects in São Paulo, Brazil. Mem Inst Oswaldo Cruz. 2018; 113(2): 123-6
• [62] Braundmeier-Fleming A, Russell NT, Yang W, et al. Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Sci Rep. 2016; 6(1): 1-12
• [63] Towner RA, Wisniewski AB, Wu DH, et al. A feasibility study to determine whether clinical contrast enhanced magnetic resonance imaging can detect increased bladder permeability in patients with interstitial cystitis. J Urol. 2015; 193(2): 631-8
• [64] Akiyama Y, Morikawa T, Maeda D, et al. Increased CXCR3 expression of infiltrating plasma cells in hunner type interstitial cystitis. Sci Rep. 2016; 6(1): 1-11
• [65] Al-Khikani FH. Study of the antibiotic-resistant Escherichia coli isolated from urinary tract. Assam Journal of Internal Medicine 2023 Jul 1; 13(2): 64-7
• [66] Taylor RA, Moore CL, Cheung KH, Brandt C. Predicting urinary tract infections in the emergency department with machine learning. PLoS One 2019; 13(3): e0194085
• [67] Al-Khikani FH, Fareeq HT, Mohammed HA, Jassem BW, Abdul-Hussein BW, Banay AA, Jawad BA, Hamza TH, Hilal BM. Synergistic and antagonistic effects of vinegar and sodium bicarbonate on antibiotic-resistant Escherichia coli. Advances in Biomedical and Health Sciences 2024 Apr 1; 3(2): 58-61
• [68] Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2014; 369(13): 1227-36
• [69] King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2015; 11(1): 65-79
• [70] Niemirowicz K, Durnaś B, Tokajuk G, et al. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. Sci Rep. 2016; 6(1): 1-11
• [71] Al-Khikani FH, Jasim SH, Abedulameeralhusayni A. Fosfomycin Sensitivity among Escherichia coli and Gram-positive Cocci Uropathogen. Indian Journal of Medical Specialities 2024 Apr 1; 15(2): 143-4
• [72] Clemens JQ, Markossian T, Calhoun EA. Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome. Urology 2013; 75(3): 728-33
• [73] Alhusayni AA, Al-Khikani FH, Aljaburi HK, Alkareawiu BA, Abadi RM. Antibiotic susceptibility profile of bacterial uropathogens in Al-Shomali General Hospital, Babylon, Iraq. Journal of Preventive, Diagnostic and Treatment Strategies in Medicine. 2022 Oct 1; 1(4): 240-5
• [74] Kanter G, Komesu YM, Qaedan F, et al. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Int Urogynecol J. 2016; 27(11): 1705-11
• [75] Verghese TS, Riordain RN, Champaneria R, Latthe PM. Acupuncture for chronic pelvic pain in women: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2016; 200: 57-64
• [76] Morgan DJ, Malani PN, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA. 2019; 312(6): 579-80
• [77] Hotez PJ, Alvarado M, Basáñez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014; 8(7): e2865
• [78] Khanna T, Cheyney M, Engle M. Cultural competency in health care: Evaluating the outcomes of a cultural competency training among health care professionals. J Cult Divers. 2016; 23(3)

• Document Type: article